Recently, an article published in the British Journal of Obstetrics and Gynecology has shown that while transvaginal mesh products are effective in the treatment of damaged uterine or vaginal walls following pelvic organ prolapse, these products carry a risk of mesh erosion as high as 10%.
Analyzing federal databases that keep medical records from 1950 to 2007, the Feiner et al. (2008) team found that transvaginal mesh is up to 95% effective in the repair of damaged tissues as a result of pelvic organ prolapse but that the complication of vaginal mesh erosion remained between 4.6 and 10.7%.
This research corroborates the findings of many other medical researchers, such as Gopal Badlani (2012) who found that vaginal mesh erosion occurred in 10.3% of cases. Strengthening his report, Badlani’s data was collected using a study that reviewed over 10,000 patients.
Due to the fact that the manufacturers of transvaginal mesh products have time and again failed to include the findings of recent medical research in the warning labels on their products, a number of transvaginal mesh lawsuits are currently being filed.
As it currently stands, the United States FDA has decided to review the efficacy and safety of these products as more than 1,000 reports of negative side-effects related to transvaginal mesh have been reported.
If you or a loved one used transvaginal mesh and experienced vaginal mesh erosion, you may be eligible to significant financial compensation through a transvaginal mesh lawsuit. For more information or a free case consultation, you may contact our team of Transvaginal Mesh Lawyers by phone at (855) 452-5529 or by e-mail at email@example.com.
Our Transvaginal Mesh Lawsuit Information page is a great place to start if you have additional questions about Transvaginal Mesh.